Asked by: Lord Farmer (Conservative - Life peer)
Question to the Department of Health and Social Care:
To ask Her Majesty's Government whether they have plans to publicise findings from the SIREN study, and data from this and other studies about the protective effects against reinfection and serious illness of infection-acquired immunity (unboosted by vaccination).
Answered by Lord Kamall
Scientific papers and reports from the SIREN study are being publicised online through the UK Health Security Agency (UKHSA) and in scientific journals. In addition, the study’s participant retention programme includes regular webinars, newsletters and videos to share its results and findings.
On 22 July 2022, the UKHSA published SARS-CoV-2 variants of concern and variants under investigation in England Technical briefing 44 with data on trends in primary infections and reinfections. A copy of the technical briefing is attached.
The Office for National Statistics’ COVID-19 Infection Survey publishes analysis on re-infections and the associated risk factors and symptoms. An updated assessment, Coronavirus (COVID-19) Infection Survey, characteristics of people testing positive for COVID-19, UK: 20 July 2022. Characteristics of people testing positive for COVID-19 from the Coronavirus (COVID-19) Infection Survey, was published on 20 July 2022. A copy of the assessment is attached.
Asked by: Lord Farmer (Conservative - Life peer)
Question to the Department of Health and Social Care:
To ask Her Majesty's Government, further to the statement by the Minister for Women's Health on 20 July, what evidence they have to support the claim that that there is a “gender health gap” adversely affecting women and the Government needs to “ensure women receive the same standards of care as men”, given that men die younger than women and are more likely to die from heart disease, suicide, COVID and diabetes.
Answered by Lord Kamall
The Women’s Health Strategy for England found that although on average women in the United Kingdom live longer than men, women spend a quarter of their lives in ill-health and disability compared to approximately one fifth of men. Disability-free life expectancy has reduced at almost twice the rate for women in England compared to men. A copy of the Women’s Health Strategy for England is attached.
The call for evidence which informed the Women’s Health Strategy received approximately 100,000 responses from individuals and over 400 written responses from organisations with expertise in women’s health. The Results of the ‘Women’s Health – Let's talk about it’ survey found that women have been under-represented in research studies, including clinical trials, therefore there is less understanding of how general health conditions and disabilities such as cardiovascular disease and mental health conditions can affect women and men differently. Respondents also reported that there is insufficient understanding of conditions which solely impact women, such as endometriosis or the menopause. A copy of the Results of the ‘women’s health – let's talk about it survey is attached.
The responses received to the call for evidence from organisations and experts in women’s healthcare also highlighted the need for improved education and training in women’s health conditions for healthcare professionals. Respondents also reported a lack of awareness of women’s health issues among some healthcare professionals, including the causes of infertility and treatment for gynaecological conditions. A copy of the Results of the of the written evidence submitted by organisations and experts is attached.
Asked by: Lord Farmer (Conservative - Life peer)
Question to the Department of Health and Social Care:
To ask Her Majesty's Government what was the cost to the NHS of remedial surgical interventions following surgical interventions intended to reduce gender dysphoria, and improve health, quality of life and social functioning in people who have gender dysphoria, in each year since 2019.
Answered by Lord Kamall
Surgical interventions intended to reduce gender dysphoria commissioned by the National Health Service are recorded in three categories: masculinising genital surgery; feminising genital surgery; and masculinising chest surgery. The following table shows the number of surgical interventions in each category and the associated costs in 2019/20.
Surgical interventions Cost
Masculinising genital surgery 573 £4,892,000
Feminising genital surgery 528 c. £8,944,381*
Masculinising chest surgery Not known*
Note:
*The cost of feminising genital and masculinising chest surgery is combined as some surgical providers offer both interventions therefore the costs are not recorded separately in data held by NHS England. The combined cost does not include the full cost of masculinising chest surgery, as this was partially funded by clinical commissioning groups in 2019/20.
Information on the number of surgical interventions for feminising genital surgery and masculinising chest surgery in 2020/21 is not currently held centrally. However, this data is expected to be available within the first quarter of 2022/23. While the allocated budget for specialist surgical procedures on the gender dysphoria pathway in 2020/21 was £19 million, actual spend can only be determined once the data on surgical numbers is available. The information requested on revision surgery is not available in the format requested this procedure was not recorded via a separate pathway until October 2020.
Asked by: Lord Farmer (Conservative - Life peer)
Question to the Department of Health and Social Care:
To ask Her Majesty's Government how many remedial surgical interventions were commissioned by the NHS following surgical interventions intended to reduce gender dysphoria, and improve health, quality of life and social functioning in people who have gender dysphoria, in each year since 2019.
Answered by Lord Kamall
Surgical interventions intended to reduce gender dysphoria commissioned by the National Health Service are recorded in three categories: masculinising genital surgery; feminising genital surgery; and masculinising chest surgery. The following table shows the number of surgical interventions in each category and the associated costs in 2019/20.
Surgical interventions Cost
Masculinising genital surgery 573 £4,892,000
Feminising genital surgery 528 c. £8,944,381*
Masculinising chest surgery Not known*
Note:
*The cost of feminising genital and masculinising chest surgery is combined as some surgical providers offer both interventions therefore the costs are not recorded separately in data held by NHS England. The combined cost does not include the full cost of masculinising chest surgery, as this was partially funded by clinical commissioning groups in 2019/20.
Information on the number of surgical interventions for feminising genital surgery and masculinising chest surgery in 2020/21 is not currently held centrally. However, this data is expected to be available within the first quarter of 2022/23. While the allocated budget for specialist surgical procedures on the gender dysphoria pathway in 2020/21 was £19 million, actual spend can only be determined once the data on surgical numbers is available. The information requested on revision surgery is not available in the format requested this procedure was not recorded via a separate pathway until October 2020.
Asked by: Lord Farmer (Conservative - Life peer)
Question to the Department of Health and Social Care:
To ask Her Majesty's Government what was the cost to the NHS of surgical interventions intended to reduce gender dysphoria, and improve health, quality of life and social functioning in people who have gender dysphoria, in each year since 2019.
Answered by Lord Kamall
Surgical interventions intended to reduce gender dysphoria commissioned by the National Health Service are recorded in three categories: masculinising genital surgery; feminising genital surgery; and masculinising chest surgery. The following table shows the number of surgical interventions in each category and the associated costs in 2019/20.
Surgical interventions Cost
Masculinising genital surgery 573 £4,892,000
Feminising genital surgery 528 c. £8,944,381*
Masculinising chest surgery Not known*
Note:
*The cost of feminising genital and masculinising chest surgery is combined as some surgical providers offer both interventions therefore the costs are not recorded separately in data held by NHS England. The combined cost does not include the full cost of masculinising chest surgery, as this was partially funded by clinical commissioning groups in 2019/20.
Information on the number of surgical interventions for feminising genital surgery and masculinising chest surgery in 2020/21 is not currently held centrally. However, this data is expected to be available within the first quarter of 2022/23. While the allocated budget for specialist surgical procedures on the gender dysphoria pathway in 2020/21 was £19 million, actual spend can only be determined once the data on surgical numbers is available. The information requested on revision surgery is not available in the format requested this procedure was not recorded via a separate pathway until October 2020.
Asked by: Lord Farmer (Conservative - Life peer)
Question to the Department of Health and Social Care:
To ask Her Majesty's Government how many surgical interventions intended to reduce gender dysphoria, and improve health, quality of life and social functioning in people who have gender dysphoria, have been commissioned by the NHS in each year since 2019; and of these, how many were (1) masculinising genital surgery, and (2) feminising genital surgery.
Answered by Lord Kamall
Surgical interventions intended to reduce gender dysphoria commissioned by the National Health Service are recorded in three categories: masculinising genital surgery; feminising genital surgery; and masculinising chest surgery. The following table shows the number of surgical interventions in each category and the associated costs in 2019/20.
Surgical interventions Cost
Masculinising genital surgery 573 £4,892,000
Feminising genital surgery 528 c. £8,944,381*
Masculinising chest surgery Not known*
Note:
*The cost of feminising genital and masculinising chest surgery is combined as some surgical providers offer both interventions therefore the costs are not recorded separately in data held by NHS England. The combined cost does not include the full cost of masculinising chest surgery, as this was partially funded by clinical commissioning groups in 2019/20.
Information on the number of surgical interventions for feminising genital surgery and masculinising chest surgery in 2020/21 is not currently held centrally. However, this data is expected to be available within the first quarter of 2022/23. While the allocated budget for specialist surgical procedures on the gender dysphoria pathway in 2020/21 was £19 million, actual spend can only be determined once the data on surgical numbers is available. The information requested on revision surgery is not available in the format requested this procedure was not recorded via a separate pathway until October 2020.
Asked by: Lord Farmer (Conservative - Life peer)
Question to the Department of Health and Social Care:
To ask Her Majesty's Government whether they are aware of any research on the effects of continuous mask-wearing over long periods; and if so what are the findings of that research.
Answered by Lord Bethell
Public Health England has not conducted any research nor conducted a review of research evidence on this topic.
Asked by: Lord Farmer (Conservative - Life peer)
Question to the Department of Health and Social Care:
To ask Her Majesty's Government how many COVID-19 patients admitted to hospital aged 80 or over received ICU treatment; and how many of those patients survived.
Answered by Lord Bethell
The data is not available in the format requested.
Asked by: Lord Farmer (Conservative - Life peer)
Question to the Department of Health and Social Care:
To ask Her Majesty's Government how many COVID-19 patients admitted to hospital aged 80 or over died of the disease without receiving ICU treatment before being discharged.
Answered by Lord Bethell
The data is not available in the format requested.
Asked by: Lord Farmer (Conservative - Life peer)
Question to the Department of Health and Social Care:
Her Majesty's Government how much funding was allocated in 2016–17 to treat alcohol addiction in prisons.
Answered by Lord O'Shaughnessy
The Department does not hold this information.